Pfizer Inks Global License to Genomatix Software and Databases(PresseBox) (AnnArbor, MI, )
"Adding Genomatix to Pfizer's existing genomics software capabilities was a natural choice." said Peter Grant, CEO of Genomatix Software, Inc. "Our broad set of capabilities are a good compliment to those that Pfizer already has in house. We are pleased to be a part of Pfizer's significant effort in molecular genomics. We believe our tools will provide a great value to their research effort, but the proof is always in the results. Now the fun really begins!" he concluded.